UNCY icon

Unicycive Therapeutics
UNCY

Overview Fund Activity

19 hedge funds and large institutions have $24.6M invested in Unicycive Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 14 closing their positions.

Holders
19
Holders Change
-10
Holders Change %
-34.48%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
13
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$104K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$56.2K
3
Lazard Asset Management
3
Lazard Asset Management
New York
$55K
4
SS
4
SBI Securities
Japan
$2.64K
5
HI
5
Harbour Investments
Wisconsin
$477

Top Sellers

1
VC
1
Vivo Capital
California
$5.42M
2
GPP
2
Great Point Partners
Connecticut
$3.8M
3
OCA
3
Octagon Capital Advisors
New York
$4.77M
4
NCM
4
Nantahala Capital Management
Connecticut
$4.56M
5
LGM
5
Logos Global Management
California
$2.26M
Name Market Value Shares Shares
Change 		Shares
Change %
CF
26
Cantor Fitzgerald
New York
– – -32,971 Closed
Creative Planning
27
Creative Planning
Kansas
– – -25,910 Closed
HF
28
HRT Financial
New York
– – -17,816 Closed
TCM
29
Tandem Capital Management
New Jersey
– – -15,500 Closed
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
– – -14,840 Closed
TSS
31
Two Sigma Securities
New York
– – -12,044 Closed
UBS Group
32
UBS Group
Switzerland
– – -9,552 Closed
Barclays
33
Barclays
United Kingdom
$0 80 +80 New
1
2